Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • hvm
    Junior Member
    • Apr 2013
    • 1

    Novoalign repeat strategy for SNP analysis

    Novoalign offers the following strategies to deal with multireads (reads mapping to multiple locations):

    None: No alignments will be reported. The read will be reported as a status R with a count of the number of alignments. No alignment locations will be reported.

    Random: A single alignment location is randomly chosen from amongst the alignment results. The choice is made using posterior alignment probabilities.

    All: All alignment locations are reported. Note, that this is all alignments with a score within 5 points of the best alignment unless you use the R99 option to extend the range.

    Exhaustive: This option bypasses the iterative alignment process and the normal repeat alignment detection. It finds all alignments with a score no worse than the threshold (t 99 option) and reports all the locations.

    0.99: Sets a posterior probability threshold. Any alignment with a posterior probability, P(Ai| R, G) greater than this value will be reported. Eaxmple: r 0.01 will report all alignments with a probability greater then 0.01.

    Which of the options should be used for SNP detection?

    If "None" is used then SNPs in some repetitive regions will be completely omitted.

    Using the "All" option will avoid it, but can introduce fake SNPs (if reads from slightly different repetitive regions are mapped to the same location).

    The –R option can limit the definition of alignments as "identical" based on the alignment score. "This score difference is set by the 'R99' option and defaults to 5 which corresponds to the best alignment being approximately 3 times more probable than the next best alignment. For example, two alignments with probabilities 0.7 (score 1) and 0.3 (score = 5) would be considered as multiple alignments to the read. Two alignments with probabilities 0.8 (Score 0) and 0.2 ( score 7) would be treated as a unique alignment to the location with the higher probability."

    So is using "All" with "-R 1" the best setting for SNP detection?
    Last edited by hvm; 04-15-2013, 03:38 AM.
  • zee
    NGS specialist
    • Apr 2008
    • 249

    #2
    Hi

    We typically would like to filter out ambiguous mapping reads when calling variants. Novoalign scores all of the cases above with a mapping quality of zero. In most cases our users usually set default reporting strategy and fitter mapQ 0 reads before calling SNPs.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Working...